10th Annual Echo Florida
October 8-10, 2022
Disney’s Yacht & Beach Club Resort
Walt Disney World, Florida
Echo Florida is a comprehensive review of cardiovascular ultrasound, including dedicated sessions on coronary artery disease (including stress testing), valvular heart disease, heart failure, emerging technologies, complex congenital heart disease, and case-based demonstrations on the role of 2D and real-time 3D/4D echocardiography.
Course Learning Objectives
Upon completion of these sessions, participants will be better able to:
- Analyze and quantify systolic and diastolic function by echocardiography and understand the role of strain imaging.
- Identify indications for echocardiographic contrast agents.
- Describe the findings of echocardiography in various forms of infective endocarditis.
- Quantify valvular regurgitation using PISA.
- Describe the role of standard and advanced echo (3D echo, strain) in contemporary echocardiography.
- Describe the selection process for patients with TAVR and the role of echocardiography in monitoring patients who have undergone TAVR.
- Recognize and assess the role of echocardiography in the deployment of percutaneous devices, such as appendage occlusion devices.
- Describe echocardiographic features of common complex congenital lesions found in adults.
- Explain normal and abnormal findings of prosthetic valve function.
- Understand the complementary nature of competing imaging technologies, such as MRI and CT.
- Describe echocardiographic features of hypertrophic and infiltrative myopathies.
Workshops – Optional Small Group Sessions
Small group workshops offer registered participants the opportunity to get one-on-one time with faculty in a hands-on learning experience. Workshops are included with registration and the total number of CME credits offered. Pre-registration is required for these workshops.
Questions? Please submit an Education & Meetings Help Desk Ticket, or call ASE at 919-861-5574 (press 2 for meetings).
Echo Florida Science & Technology Theater
Saturday, October 8, 2022 | 12:30 PM – 1:30 PM
Transthyretin Amyloid Cardiomyopathy (ATTR-CM): Evaluating Clinical Findings to Support Earlier Diagnosis and Management
Sponsored by: 
Transthyretin amyloid cardiomyopathy (or ATTR-CM) is a progressive disease that frequently presents as heart failure. ATTR-CM is underrecognized, with symptoms that can span multiple organ systems, resulting in delayed diagnosis and increased disease burden. This program provides an overview of ATTR-CM pathology and highlights the signs and symptoms that raise suspicion of ATTR-CM, as well as diagnostic approaches used to confirm suspicion. The program also presents clinical data supporting an oral treatment option for patients with this life-threatening disease.